Evogene Ltd. (NASDAQ: EVGN) flaunted slowness of 0.00% at $2.92, as the Stock market unbolted on N/A. During the day, the stock rose to N/A and sunk to N/A before settling in for the price of $2.92 at the close. Taking a more long-term approach, EVGN posted a 52-week range of $2.38-$10.24.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -37.80%. Meanwhile, its Annual Earning per share during the time was -4.10%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -18.00%. This publicly-traded company’s shares outstanding now amounts to $38.96 million, simultaneously with a float of $38.06 million. The organization now has a market capitalization sitting at $112.01 million. At the time of writing, stock’s 50-day Moving Average stood at $2.89, while the 200-day Moving Average is $4.35.
Let’s gauge the efficiency of the firm, which has a total of 150 employees. It has generated 27,302 per worker during the last fiscal year. Meanwhile, its income per employee was -613,617. The stock had 0.64 Receivables turnover and 0.01 Total Asset turnover. For the Profitability, stocks gross margin was -217.40, operating margin was -2580.29 and Pretax Margin of -2516.73.
Evogene Ltd. (EVGN) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Evogene Ltd. industry. Evogene Ltd.’s current insider ownership accounts for 10.59%, in contrast to 18.70% institutional ownership.
Evogene Ltd. (EVGN) Earnings and Revenue Records
Going through the last 3-months fiscal report unveiled on the 6/29/2021, it has been observed that the corporation posted -$0.15 earnings per share (EPS) during the time that was better the consensus figure (set at -$0.18) by $0.03. This company achieved a net margin of -2247.50 while generating a return on equity of -50.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
Evogene Ltd.’s EPS decrease for this current 12-month fiscal period is -18.00% and is forecasted to reach -0.67 in the upcoming year.
Evogene Ltd. (NASDAQ: EVGN) Trading Performance Indicators
Let’s observe the current performance indicators for Evogene Ltd. (EVGN). It’s Quick Ratio in the last reported quarter now stands at 13.60. The Stock has managed to achieve an average true range (ATR) of 0.21. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 86.16.
In the same vein, EVGN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.75, a figure that is expected to reach -0.17 in the next quarter, and analysts are predicting that it will be -0.67 at the market close of one year from today.
Technical Analysis of Evogene Ltd. (EVGN)
Now, what If we examine the latest scores posted by [Evogene Ltd., EVGN]. During the last 5-days, its volume was lower the volume of 0.87 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 38.36% While, its Average True Range was 0.20.
Raw Stochastic average of Evogene Ltd. (EVGN) in the period of the previous 100 days is set at 27.51%, which indicates a major rise in contrast to 22.35% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 67.43% that was lower than 71.64% volatility it exhibited in the past 100-days period.